SANMINIT Medical Journal
Female sexual interest/arousal disorder (FSIAD), previously termed hypoactive sexual desire disorder and female sexual arousal disorder, is a prevalent condition that primarily affects older and postmenopausal women. FSIAD encompasses a lack of or significantly reduced sexual interest/arousal, often leading to distress or interpersonal difficulties. This condition is frequently underdiagnosed due to sociocultural barriers and limited clinician understanding. Diagnostic criteria include several symptoms, such as reduced sexual thoughts or fantasies, decreased initiation of sexual activity, and diminished sexual pleasure. Diagnosis also requires the presence of distress related to these symptoms for at least 6 months. Various factors, including physiological, psychological, and sociological elements, may contribute to FSIAD. Management approaches range from counseling and therapy to United States Food and Drug Administration-approved and off-label medications. Monitoring and individualizing treatment are crucial due to potential adverse effects and variability in response.
In this course, healthcare professionals gain an in-depth understanding of the etiology, prevalence, diagnostic criteria, and current therapeutic approaches of FSIAD. Participants learn to individualize treatment plans, considering psychotherapeutic and pharmacological options to improve patient care. The course also emphasizes the importance of interprofessional collaboration, with clinicians working alongside psychologists, therapists, and other specialists to develop comprehensive treatment plans. This teamwork ensures a holistic approach to managing FSIAD, ultimately improving patient outcomes.
Objectives: